Sage Journals: Discover world-class research

Retricted access

Case report

First published 2005-12

Acute Renal Failure Secondary to Imatinib Mesylate Treatment in Prostate Cancer

John R Foringer, Regina R Verani, Vincent M Tjia [...]

Annals of Pharmacotherapy

Retricted access

Case report

First published 2004-7

Imatinib Mesylate Treatment in Two Patients with Idiopathic Hypereosinophilic Syndrome

Sonja M Payne, Michael J Kovacs

Annals of Pharmacotherapy

Retricted access

Research article

First published 1988-5

Clinical Efficacy of Codergocrine Mesylate in Children with Learning Difficulties

K. I. Tareen, A. Bashir, K. Saeed [...]

Journal of International Medical Research

Retricted access

Review article

First published 1999-3

Nelfinavir Mesylate: A Protease Inhibitor

Vinita B Pai, Milap C Nahata

Annals of Pharmacotherapy

Free access

Research article

First published 2013-11

Eribulin Mesylate in Breast Cancer

Helena Verdaguer, Idoia Morilla, Ander Urruticoechea

Women's Health

Retricted access

Case report

First published 2014-4

Soft tissue calcification secondary to imatinib mesylate in a patient with gastrointestinal stromal tumor

Robert E Enck, Fadi Abushahin, John B Bossaer

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2005-03

Safety pharmacology of sibutramine mesylate,an anti-obesity drug

Eun-Joo Kim, Eun-Kyung Park, Kwee-Hyun Suh

Human & Experimental Toxicology

Free access

Research article

First published 2004-12

Remofovir Mesylate: A Prodrug of PMEA with Improved Liver-Targeting and Safety in Rats and Monkeys

Chin-Chung Lin, Li-Tain Yeh, Domenico Vitarella [...]

Antiviral Chemistry and Chemotherapy

Retricted access

Research article

First published 2014-6

Physico-chemical stability of eribulin mesylate containing concentrate and ready-to-administer solutions

Kirsten Spindeldreier, Judith Thiesen, Hans-Peter Lipp [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 1998-1

Effect of Infusion Rate on the Pharmacokinetics and Tolerance of Intravenous Dolasetron Mesylate

Dan C Dimmitt, Thomas L Hunt, Anthony J Spalitto [...]

Annals of Pharmacotherapy

Search results